BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32306327)

  • 1. Botulinum Hemagglutinin: Critical Protein for Adhesion and Absorption of Neurotoxin Complex in Host Intestine.
    Amatsu S; Fujinaga Y
    Methods Mol Biol; 2020; 2132():183-190. PubMed ID: 32306327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Analysis of Botulinum Hemagglutinin (HA).
    Matsumura T; Fujinaga Y
    Methods Mol Biol; 2020; 2132():191-200. PubMed ID: 32306328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption.
    Amatsu S; Matsumura T; Yutani M; Fujinaga Y
    Microbiol Immunol; 2018 Feb; 62(2):80-89. PubMed ID: 29266585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.
    Sugawara Y; Yutani M; Amatsu S; Matsumura T; Fujinaga Y
    PLoS One; 2014; 9(10):e111170. PubMed ID: 25340348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of botulinum neurotoxin in the intestine.
    Fujinaga Y; Sugawara Y; Matsumura T
    Curr Top Microbiol Immunol; 2013; 364():45-59. PubMed ID: 23239348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.
    Amatsu S; Sugawara Y; Matsumura T; Kitadokoro K; Fujinaga Y
    J Biol Chem; 2013 Dec; 288(49):35617-25. PubMed ID: 24165130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex.
    Lee K; Zhong X; Gu S; Kruel AM; Dorner MB; Perry K; Rummel A; Dong M; Jin R
    Science; 2014 Jun; 344(6190):1405-10. PubMed ID: 24948737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long journey of botulinum neurotoxins into the synapse.
    Rummel A
    Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.
    Hasegawa K; Watanabe T; Suzuki T; Yamano A; Oikawa T; Sato Y; Kouguchi H; Yoneyama T; Niwa K; Ikeda T; Ohyama T
    J Biol Chem; 2007 Aug; 282(34):24777-83. PubMed ID: 17581814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3.
    Sugawara Y; Iwamori M; Matsumura T; Yutani M; Amatsu S; Fujinaga Y
    FEBS J; 2015 Sep; 282(17):3334-47. PubMed ID: 26077172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The botulinum toxin complex meets E-cadherin on the way to its destination.
    Sugawara Y; Fujinaga Y
    Cell Adh Migr; 2011; 5(1):34-6. PubMed ID: 20935473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin.
    Sugawara Y; Matsumura T; Takegahara Y; Jin Y; Tsukasaki Y; Takeichi M; Fujinaga Y
    J Cell Biol; 2010 May; 189(4):691-700. PubMed ID: 20457762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C.
    Jin Y; Takegahara Y; Sugawara Y; Matsumura T; Fujinaga Y
    Microbiology (Reading); 2009 Jan; 155(Pt 1):35-45. PubMed ID: 19118344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of intestinal absorption of botulinum neurotoxin complex].
    Matsumura T
    Nihon Saikingaku Zasshi; 2019; 74(3):167-175. PubMed ID: 31787706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational divergence in the HA-33/HA-17 trimer of serotype C and D botulinum toxin complex.
    Sagane Y; Hayashi S; Akiyama T; Matsumoto T; Hasegawa K; Yamano A; Suzuki T; Niwa K; Watanabe T; Yajima S
    Biochem Biophys Res Commun; 2016 Aug; 476(4):280-285. PubMed ID: 27237978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular engineering of a minimal E-cadherin inhibitor protein derived from Clostridium botulinum hemagglutinin.
    Amatsu S; Matsumura T; Zuka M; Fujinaga Y
    J Biol Chem; 2023 Mar; 299(3):102944. PubMed ID: 36707052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete subunit structure of serotype C and D botulinum progenitor toxin complex induces vacuolation in the specific epithelial cell line.
    Huang IH; Miyashita SI; Hata T; Karatsu S; Hosoya K; Sagane Y
    Biochem Biophys Res Commun; 2022 Dec; 632():55-61. PubMed ID: 36201881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the interaction region between hemagglutinin components of the botulinum toxin complex.
    Suzuki T; Miyashita S; Hayashi S; Miyata K; Inui K; Kondo Y; Miyazaki S; Ohyama T; Niwa K; Watanabe T; Sagane Y
    Int J Biol Macromol; 2014 Apr; 65():284-8. PubMed ID: 24472509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.
    Kalb SR; Baudys J; Barr JR
    BMC Microbiol; 2015 Oct; 15():227. PubMed ID: 26494251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible Association of the Hemagglutinin Subcomplex, HA-33/HA-17 Trimer, with the Botulinum Toxin Complex.
    Sagane Y; Mutoh S; Koizumi R; Suzuki T; Miyashita SI; Miyata K; Ohyama T; Niwa K; Watanabe T
    Protein J; 2017 Oct; 36(5):417-424. PubMed ID: 28707196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.